During the past decade, Island Gynecologic Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 16 clinical trials were completed, i.e. on average, 533.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Island Gynecologic Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "Gynecologic Oncology Group" with 5 trials sponsored, "GOG Foundation" with 3 trials sponsored, "Astex Pharmaceuticals, Inc." with 1 trials sponsored and "Daniela Matei, MD" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Island Gynecologic Oncology" #1 collaborator was "NRG Oncology" with 9 trials as a collaborator, "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Island Gynecologic Oncology" are "Fallopian Tube Mucinous Adenocarcinoma" (7 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (6 trials), "Fallopian Tube Transitional Cell Carcinoma" (6 trials), "Primary Peritoneal Serous Adenocarcinoma" (6 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (5 trials). Many other conditions were trialed in "Island Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "Island Gynecologic Oncology" are "Drug" (19 trials), "Other" (14 trials), "Biological" (10 trials), "Procedure" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (14 trials), "Quality-of-Life Assessment" (12 trials), "Carboplatin" (11 trials), "Laboratory Biomarker Analysis" (9 trials) and "Bevacizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Island Gynecologic Oncology" are 24 trials for "Female" genders.

Currently, there are NaN active trials in "Island Gynecologic Oncology". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Island Gynecologic Oncology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Island Gynecologic Oncology, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".